La sorveglianza epidemiologica delle malattie infettive in Toscana

(1)

La sorveglianza epidemiologica delle malattie infettive

in Toscana

Rapporto

Novembre 2019

La sorveglianza epidemiologica delle malattie infettive in Toscana - Rapporto 2019

ISBN 978-88-909729-3-5

(2)

La sorveglianza epidemiologica delle malattie infettive in Toscana - Rapporto 2019

Autori (in ordine alfabetico) Donatella Aquilini - ASL Toscana Centro

Alessandro Bartoloni - Università degli Studi di Firenze - AOU Careggi Angela Bechini - Università degli Studi di Firenze

Laura Bernini - ASL Toscana Sud-est Sara Boccalini - Università degli Studi di Firenze Paolo Bonanni - Università degli Studi di Firenze Cristina Bonnal - ASL Toscana Centro Sara D’Arienzo - ARS Toscana Paolo Filidei - ASL Toscana Centro Silvia Forni - ARS Toscana Fabrizio Gemmi - ARS Toscana

Elisabetta Grassi - ASL Toscana Nord-ovest Francesco Innocenti - ARS Toscana

Maddalena Innocenti - Università degli Studi di Firenze Filippo Lagi - Università degli Studi di Firenze - AOU Careggi Miriam Levi - ASL Toscana Centro

Pier Luigi Lopalco - Università di Pisa

Francesca Montagnani - AOU Senese - Università degli studi di Siena Francesca Nisticò - ASL Toscana Sud-est

Paolo Piacentini - ASL Toscana Sud-est Costanza Pierozzi - ASL Toscana Centro Monia Puglia - ARS Toscana

Camilla Puttini - ASL Toscana Sud-est Caterina Silvestri - ARS Toscana

Michele Spinicci - Università degli Studi di Firenze - AOU Careggi Cristina Stasi - ARS Toscana

Danilo Tacconi - ASL Toscana Sud-est Lara Tavoschi - Università di Pisa Michele Trezzi - ASL Toscana Centro Paola Vivani - ASL Toscana Nord-ovest Fabio Voller - ARS Toscana

Lorenzo Zammarchi - Università degli Studi di Firenze - AOU Careggi Giacomo Zanelli - AOU Senese - Università degli Studi di Siena

Coordinamento del rapporto ed elaborazioni statistiche Francesco Innocenti - ARS Toscana

Impaginazione

Elena Marchini, Caterina Baldocchi - ARS Toscana

Ringraziamenti

Un sentito ringraziamento al “Settore Prevenzione collettiva della Direzione generale Diritti di cittadinanza e coesione sociale” della Regione Toscana, in particolare a Emanuela Balocchini e Lucia Pecori, per aver fornito i dati sui casi di PDODWWLDLQIHWWLYDQRWLȴFDWLLQ7RVFDQDHODERUDWLGDOOȇ$567RVFDQDHGLQVHULWLDOOȇLQWHUQRGLTXHVWRUDSSRUWR

8QGRYHURVRULQJUD]LDPHQWRLQȴQHDQFKHDWXWWLLPHGLFLQRWLȴFDWRULHDOOHDOWUHȴJXUHVDQLWDULHFRLQYROWHQHOȵXVVRGL

QRWLȴFDGHOOHPDODWWLHLQIHWWLYH

(3)

Temi trattati

Introduzione 3

1. Malattie prevenibili tramite vaccinazione 5

1.1 Poliomielite (Lopalco PL, Tavoschi L) 5

1.2 Difterite (Lopalco PL, Tavoschi L) 7

1.3 Tetano (Lopalco PL, Tavoschi L) 9

1.4 Pertosse (Lopalco PL, Tavoschi L) 13

1.5 Morbillo (Bechini A, Innocenti M, Bonanni P, Boccalini S) 18

1.6 Parotite (Bechini A, Innocenti M, Bonanni P, Boccalini S) 25

1.7 Rosolia (Boccalini S, Innocenti M, Bonanni P, Bechini A) 32

1.8 Varicella (Boccalini S, Innocenti M, Bonanni P, Bechini A) 37

1.9 Herpes zoster (Boccalini S, Innocenti M, Bonanni P, Bechini A) 43

2. Malattie acquisite per via respiratoria 45

ΖQȵXHQ]DVWDJLRQDOH/HYL0

/HJLRQHOORVL1LVWLF´)3LDFHQWL3

7XEHUFRORVL1LVWLF´)3LDFHQWL3

0LFREDWWHULRVLQRQWXEHUFRODUL7UH]]L0

2.5 Scarlattina (Bechini A, Innocenti M, Bonanni P, Boccalini S) 69

3. Malattie trasmesse per via sessuale 73

*RQRUUHD6LOYHVWUL&$TXLOLQL'

6LȴOLGH6LOYHVWUL&$TXLOLQL'

+Ζ93XJOLD0/HYL0

$Ζ'63XJOLD0/HYL0

4. Malattie trasmesse per via alimentare/idrica 91

4.1 Campilobatteriosi (Pierozzi C) 91

%RWXOLVPR%RQQDO&

*DVWURHQWHULWHGDHFROLHQWHURHPRUUDJLFRVWHFHFRPSOLFDQ]H%RQQDO&

)HEEUHWLIRLGH*UDVVL(

*LDUGLDVL3LHUR]]L&

/LVWHULRVL%RQQDO&

6DOPRQHOORVL*UDVVL(

6KLJHOORVL*UDVVL(

7XODUHPLD3LHUR]]L&

<HUVLQLRVL3LHUR]]L&

%UXFHOORVL%RQQDO&

4.12 Leptospirosi (Pierozzi C) 127

(4)

5. Malattie trasmesse da vettore 131

&KLNXQJXQ\D6SLQLFFL0=DPPDUFKL/%DUWRORQL$

'HQJXH6SLQLFFL0=DPPDUFKL/%DUWRORQL$

:HVW1LOH6SLQLFFL0=DPPDUFKL/%DUWRORQL$

=LND=DPPDUFKL/6SLQLFFL0%DUWRORQL$

/HLVKPDQLRVLFXWDQHD=DPPDUFKL/6SLQLFFL0%DUWRORQL$

/HLVKPDQLRVLYLVFHUDOH=DPPDUFKL/6SLQLFFL0%DUWRORQL$

0DODULD6SLQLFFL0=DPPDUFKL/%DUWRORQL$

%RUUHOLRVL$TXLOLQL'

5LFNHWWVLRVL$TXLOLQL'

9LUXV7RVFDQD6SLQLFFL0=DPPDUFKL/%DUWRORQL$

6. Epatiti virali 157

(SDWLWH$%HUQLQL/6WDVL&7DFFRQL'

(SDWLWH%%HUQLQL/6WDVL&7DFFRQL'

(SDWLWH&%HUQLQL/6WDVL&7DFFRQL'

(SDWLWH'%HUQLQL/6WDVL&7DFFRQL'

(SDWLWH(%HUQLQL/6WDVL&7DFFRQL'

7. Malattie batteriche invasive 173

0DODWWLHEDWWHULFKHLQYDVLYHGDHPRȴOR)LOLGHL3

0DODWWLHEDWWHULFKHLQYDVLYHGDPHQLQJRFRFFR)LOLGHL3

0DODWWLHEDWWHULFKHLQYDVLYHGDSQHXPRFRFFR)LOLGHL3

8. Antibiotico-resistenza

*HPPL)'ȇ$ULHQ]R6)RUQL6

185 Approfondimenti su tematiche di particolare interesse 189

ΖΖPSDWWRVXOOHFRSHUWXUHYDFFLQDOLGHOODOHJJHFKHSUHYHGHYDFFLQD]LRQL

REEOLJDWRULHSHULPLQRULGLHW¢DQQL/RSDOFR3/7DYRVFKL/

ΖΖ9DULFHOODHG+HUSHV]RVWHUWHPSRGLSHQVDUHDGXQDSSURFFLRGLSUHYHQ]LRQHJOREDOH

(Bechini A, Bonanni P, Boccalini S)

ΖΖΖΖQIH]LRQHGDFORVWULGLRLGHVSUHFHGHQWHPHQWHFORVWULGLXPGLɝFLOH

/DJL)'ȇ$ULHQ]R6)RUQL6*HPPL)%DUWRORQL$

Ζ9ΖO3DSLOORPDYLUXVXPDQRHGLFRQGLORPL9LYDQL3

90\FREDFWHULXPFKLPDHUD3XWWLQL&=DQHOOL*0RQWDJQDQL)

Appendice statistica 217

(5)

A

PPROFONDIMENTISU TEMATICHEDIPARTICOLAREINTERESSE

213

V - Mycobacterium chimaera

Introduzione

0\FREDFWHULXP FKLPDHUD GHVFULWWR SHU OD SULPD YROWD QHO ª XQ PLFREDWWHULR QRQ WXEHUFRODUH D

lenta crescita (appartenente al gruppo del 0\FREDFWHULXP $YLXP &RPSOH[ 0$& GL΍XVR LQ QDWXUD

SUHYDOHQWHPHQWHLQDPELHQWLDFTXRVLHGXPLGLHFDSDFHGLSUROLIHUDUHDOOȇLQWHUQRGLXQELRȴOPDGHVRDOOH

VXSHUȴFLQRUPDOPHQWHFRQVLGHUDWRXQPLFURRUJDQLVPRDEDVVDYLUXOHQ]DHUDUDPHQWHFDXVDPDODWWLD

QHOOȇXRPRORFDOL]]DWRWLSLFDPHQWHDOLYHOORSROPRQDUHLQSD]LHQWLFRQVRWWRVWDQWLD΍H]LRQLUHVSLUDWRULH

FURQLFKHRVRWWRIRUPDGLPDQLIHVWD]LRQHGLVVHPLQDWDJUDYHLQSD]LHQWLLPPXQRFRPSURPHVVL/ȇLQDOD]LRQH

GLSDUWLFHOOHGLDHUHRVROFRQWDPLQDWHUDSSUHVHQWDODVRUJHQWHGȇLQIH]LRQHQHOOȇXRPRHQRQVRQRULSRUWDWL

casi di trasmissione interumana.

'DOVRQRVWDWHVHJQDODWHDQFKHLQIH]LRQLJUDYLLQSD]LHQWLVRWWRSRVWLDGLQWHUYHQWLFDUGLRFKLUXUJLFL

in relazione alla contaminazione da parte di 0FKLPDHUDGLGLVSRVLWLYLGLULVFDOGDPHQWRUD΍UHGGDPHQWR

+HDWHU&RROHU8QLWV+&8XWLOL]]DWLGXUDQWHODFLUFROD]LRQHH[WUDFRUSRUHD

ΖOSHULRGRGLLQFXED]LRQHULVXOWDOXQJRFRQXQDPHGLDQDGLPHVLGDOOȇLQWHUYHQWRFKLUXUJLFRUDQJH

PHVLHGLOWDVVRGLPRUWDOLW¢SX´DUULYDUHȴQRDOΖVHJQLHLVLQWRPLDVVRFLDWLVRQRJHQHUDOPHQWH

DVSHFLȴFLHGLOWUDWWDPHQWRDQWLELRWLFRGLOXQJDGXUDWDFRVWLWXLWRGDOOȇDVVRFLD]LRQHGLSL»PROHFROHª

JUDYDWRGDHOHYDWRULVFKLRGLWRVVLFLW¢6RQRVWDWLGHVFULWWLFDVLVLDLQ3DHVL([WUD(XURSHL86$$XVWUDOLD

&DQDGD+RQJ.RQJFKHLQGLYHUVL3DHVL(XURSHLWUDFXL)UDQFLDΖUODQGD6YL]]HUD2ODQGD*HUPDQLD

3DHVL %DVVL 6SDJQD 5HJQR 8QLWR H UHFHQWHPHQWH DQFKH LQ ΖWDOLD /D UHDOH LQFLGHQ]D GHOOȇLQIH]LRQH

FDUGLRFKLUXUJLFDGD0FKLPDHUDQRQªQRWDDFDXVDGHOOHGLɝFROW¢GLDJQRVWLFKHFOLQLFKHHPLFURELRORJLFKH

PDYHURVLPLOPHQWHEDVVDFRQXQDVWLPDGLFDVLSHUSHUVRQHDQQRFRQFDVLRJQL

SURFHGXUHDULVFKLRVXOODEDVHGLGDWLUDFFROWLWUDLOHLOQHO5HJQR8QLWR

Epidemiologia in Italia e in Toscana

ΖQΖWDOLDLOSULPRFDVRGLLQIH]LRQHªVWDWRVHJQDODWRDȴQHJLXJQRLQ9HQHWRLQXQSD]LHQWHVRWWRSRVWR

DLQWHUYHQWRFDUGLRFKLUXUJLFRQHOPHQWUHLOSULPRFDVRGHVFULWWRLQOHWWHUDWXUDULVDOHDOLQ

XQD SD]LHQWH RSHUDWD QHO $G $SULOH VRQR VWDWL VHJQDODWL DO 0LQLVWHUR GHOOD 6DOXWH FDVL

GLLQIH]LRQHLQYDVLYDGD0FKLPDHUDLQFOXVLGHFHVVLLQUHJLRQLHGLVSRVLWLYL+&8GLVWULEXLWLLQ

UHJLRQLFKHVRQRULVXOWDWLFRQWDPLQDWL

ΖQ 7RVFDQD ª LQ FRUVR XQȇLQGDJLQH UHWURVSHWWLYD VXOOȇDQGDPHQWR GHOOȇLQIH]LRQH GD PLFREDWWHUL QRQ

WXEHUFRODUL1701RQ7XEHUFXORXV0\FREDFWHULDSURPRVVDGDO*UXSSR170GHOODVH]LRQHUHJLRQDOH

GHOOD6Ζ0Ζ76RFLHW¢ΖWDOLDQDGL0DODWWLHΖQIHWWLYHH7URSLFDOLLQFROODERUD]LRQHFRQL&HQWULGL3QHXPRORJLD

HGLODERUDWRULGL0LFURELRORJLD'D*HQQDLRDOSULPRVHPHVWUHVRQRVWDWLLVRODWL170H

WUDTXHVWLVRQRULVXOWDWLHVVHUH0FKLPDHUDWXWWLLGHQWLȴFDWLGDOOD62'0LFURELRORJLDGHOOȇ$28

&DUHJJL&HQWURGLULIHULPHQWR5HJLRQDOHHGLSURYHQLHQ]DGDOOD$6/7RVFDQD&HQWURLVRODWL SURYHQJRQR GD FDPSLRQL UHVSLUDWRUL LO GL TXHVWL VRQR EURQFRODYDJJL R EURQFRDVSLUDWL LO UHVWR

HVFUHDWLGDIHFLXQFDPSLRQHGDOLTXRUHXQRGDDVSLUDWRJDVWULFRQRQVSHFLȴFDWLΖVRJJHWWL

FRLQYROWLKDQQRXQȇHW¢PHGLDQDGLDQQLUDQJHDQQLHVRQRSUHYDOHQWHPHQWHPDVFKL1RQ

ULVXOWDQRLQYHFHFDVLGLLQIH]LRQHGD0FKLPDHUDLQSD]LHQWLVRWWRSRVWLDLQWHUYHQWLFDUGLRFKLUXUJLFLLQ

2VSHGDOL7RVFDQLDOVHWWHPEUH

Percorso clinico-assistenziale

6LDLO0LQLVWHURGHOOD6DOXWH&LUFRODULPLQLVWHULDOLGHO*HQQDLRH$SULOHFKHOD5HJLRQH7RVFDQD

'HOLEHUDQ0DU]RKDQQRGHȴQLWROHUDFFRPDQGD]LRQLHGLSHUFRUVLRSHUDWLYLSHULOFRQWUROOR

GHOOȇLQIH]LRQHGD0FKLPDHUD.

(6)

214

L

ASORVEGLIANZADELLE MALATTIEINFETTIVEIN

T

OSCANA 'HȴQL]LRQHGLFDVR

3HUODGHȴQL]LRQHGLXQFDVRGLLQIH]LRQHGD0FKLPDHUDªQHFHVVDULRFRQVLGHUDUHFULWHULFOLQLFL$HGL

HVSRVL]LRQH%0LQLVWHURGHOOD6DOXWH

$&5Ζ7(5Ζ&/Ζ1Ζ&Ζ

$OPHQRXQRWUDLVHJXHQWL

• Endocardite della protesi valvolare

• ΖQIH]LRQHGHOODSURWHVLYDOYRODUH

• ΖQIH]LRQHGHOODIHULWDGDVWHUQRWRPLD

• Mediastinite

• 0DQLIHVWD]LRQLGLLQIH]LRQHGLVVHPLQDWDVHSVLLQFOXVHPDQLIHVWD]LRQLHPEROLFKHHLPPXQRORJLFKH

(ad es. splenomegalia, artrite, osteomielite, spondilodisciti, coinvolgimento del midollo osseo con FLWRSHQLDFRULRUHWLQLWHFRLQYROJLPHQWRSROPRQDUHHSDWLWHQHIULWHPLRFDUGLWHPDQLIHVWD]LRQLGHO

SNC, ascessi settici, sarcoidosi, emolisi, rottura del rene, epatite).

5LHQWUDQR QHOOD VLQWRPDWRORJLD FKH GHYH LQGXUUH DO VRVSHWWR GLDJQRVWLFR DQFKH IHEEUH SHUVLVWHQWH

perdita di peso, tosse persistente o respiro corto, astenia, sudorazione notturna, dolore articolare o PXVFRODUHGRORUHDGGRPLQDOHVHJQLGLȵRJRVLDFDULFRGHOODIHULWDFKLUXUJLFDQDXVHDRYRPLWR

%&5Ζ7(5Ζ'Ζ(6326Ζ=Ζ21(

(΍HWWXD]LRQHGLXQLQWHUYHQWRFKLUXUJLFRDWRUDFHDSHUWRFRQULFRUVRDFLUFROD]LRQHH[WUDFRUSRUHDH

HCU nei sei DQQLSUHFHGHQWLOȇLQVRUJHQ]DGHLVLQWRPLGHOOȇLQIH]LRQH

&DVR&RQIHUPDWR

8QSD]LHQWHFKHVRGGLVIDLFULWHULFOLQLFLHGLHVSRVL]LRQH(

0FKLPDHUDLVRODWRLQFROWXUDHLGHQWLȴFDWRPHGLDQWHVHTXHQ]LDPHQWRGHO'1$LQXQFDPSLRQHELRORJLFR

VLJQLȴFDWLYRSXVELRSVLDWLVVXWDOHRPDWHULDOHSURWHVLFRLPSLDQWDWR1%VRQRGDHVFOXGHUHLFDPSLRQL

provenienti dal tratto respiratorio)

&DVRSUREDELOH

8QSD]LHQWHFKHVRGGLVIDLFULWHULFOLQLFLHGLHVSRVL]LRQH(

0FKLPDHUDLGHQWLȴFDWRPHGLDQWH3&5GLUHWWDHVHTXHQ]LDPHQWRDPSOLȴFDWRGHO'1$LQXQFDPSLRQH

ELRORJLFRVLJQLȴFDWLYRSXVELRSVLDWLVVXWDOHRPDWHULDOHSURWHVLFRLPSLDQWDWR1%VRQRGDHVFOXGHUHL

FDPSLRQLSURYHQLHQWLGDOWUDWWRUHVSLUDWRULR23385(

0\FREDFWHULXPDYLXPFRPSOH[0$&LVRODWRLQFROWXUDRPHGLDQWH3&5GLUHWWDVXFDPSLRQHELRORJLFR

VLJQLȴFDWLYRSXVELRSVLDWLVVXWDOHRPDWHULDOHSURWHVLFRLPSLDQWDWR1%VRQRGDHVFOXGHUHLFDPSLRQL

SURYHQLHQWLGDOWUDWWRUHVSLUDWRULR23385(

5LOHYD]LRQHLVWRSDWRORJLFDGHOJUDQXORPDQRQFDVHRVRHPDFURIDJLVFKLXPRVLULJRQȴFRQSUHVHQ]DGL

EDFLOOLDOFRRODFLGRUHVLVWHQWLLQWHVVXWRFDUGLDFRRYDVFRODUHLQSURVVLPLW¢GLPDWHULDOHSURWHVLFRRLQXQ

FDPSLRQHGHOODIHULWDGDVWHUHRWRPLD

2JQLSD]LHQWHULFRYHUDWRRPHQRFKHSUHVHQWLFULWHULFOLQLFLHGLHVSRVL]LRQHVXGGHWWLGHYHHVVHUHLQYLDWR

DYDOXWD]LRQHVSHFLDOLVWLFDLQIHWWLYRORJLFDSHULOFRUUHWWRLQTXDGUDPHQWRHOȇLWHUGLDJQRVWLFRWHUDSHXWLFR

necessario.

Diagnosi di laboratorio e conferma

/DGLDJQRVLGLLQIH]LRQHGD0FKLPDHUDªUHVDFRPSOLFDWDGDDOFXQHVSHFLȴFKHFDUDWWHULVWLFKHLQSDUWLFRODUH

LOOXQJRSHULRGRGLODWHQ]DOȇHVRUGLRFOLQLFRDVSHFLȴFRHGLOIDWWRFKHJOLHVDPLPLFURELRORJLFLHVWUXPHQWDOL

ȴQDOL]]DWL DOOD ULFHUFD GHO JHUPH R GHOOH OHVLRQL DG HVVR FRUUHODWH ULVXOWLQR VSHVVR FRPSOHWDPHQWH

(7)

A

PPROFONDIMENTISU TEMATICHEDIPARTICOLAREINTERESSE

215

QHJDWLYL*OLHSLVRGLGLEDWWHULHPLDLQWHUPLWWHQWHDGHVHPSLRHVLWDQRVSHVVRQHOODQHJDWLYLW¢GLVLQJROH

emocolture.

Tutti i test per la ricerca di 0FKLPDHUDdevono essere eseguiti su pazienti sintomatici e prelevando FDPSLRQLFOLQLFDPHQWHVLJQLȴFDWLYLGDVLWLDQDWRPLFLSUHVXQWLVWHULOLRFDPSLRQDPHQWLHVHJXLWLVXOHVLRQL

LVWRORJLFKHVXJJHVWLYHGLLQIH]LRQHGDPLFREDWWHUL1RQFLVRQRWHVWLQJUDGRGLSUHGLUHVHXQSD]LHQWH

DVLQWRPDWLFRVYLOXSSHU¢OȇLQIH]LRQH

Campioni clinici

1HL FDVL VRVSHWWL SX´ HVVHUH HVHJXLWD OD ULFHUFD FROWXUDOH GL PLFREDWWHUL Ζ FDPSLRQL GL HOH]LRQH VRQR

FRVWLWXLWL GDOOȇHPRFROWXUD H GDOOD ELRSVLD 1RQ VRQR LQYHFH ULWHQXWL LGRQHL DL ȴQL GHOOD SUHVHQWH

VRUYHJOLDQ]DLFDPSLRQLGLRULJLQHUHVSLUDWRULDΖPHWRGLGLULOHYDPHQWREDVDWLVXOODFROWXUDULPDQJRQRLO

JROGVWDQGDUGΖOOLPLWHPDJJLRUHGLTXHVWȇXOWLPLªWXWWDYLDOHJDWRDLWHPSLOXQJKLGLLQFXED]LRQHHFUHVFLWD

HVHWWLPDQH/DVXFFHVVLYDLGHQWLȴFD]LRQHFHUWDGL0FKLPDHUDviene eseguita con sequenziamento JHQHWLFRGHJOLLVRODWLEDWWHULFL

*HQRWLSL]]D]LRQH

*OLLVRODWLGL0FKLPDHUDLQFDPSLRQLELRORJLFLVLJQLȴFDWLYLGHYRQRHVVHUHFHQWUDOL]]DWLDO/DERUDWRULRGL

0LFURELRORJLDFOLQLFDGHOOȇ$28&DUHJJLSHULOSURFHVVRGLJHQRWLSL]]D]LRQHGHOPLFREDWWHULRDOORVFRSRGL

DVVLFXUDUHODPDVVLPDVWDQGDUGL]]D]LRQHHJDUDQWLUHXQDPDJJLRUHVRUYHJOLDQ]DUHJLRQDOHGHOIHQRPHQR

1RWLȴFDHVHJQDOD]LRQH

/HLQIH]LRQLGDPLFREDWWHULQRQWXEHUFRODULVRQRJL¢VRJJHWWHDQRWLȴFDREEOLJDWRULD'0'LFHPEUH

ΖQDJJLXQWDLFDVLGLLQIH]LRQH da 0FKLPDHUDLQSD]LHQWLVRWWRSRVWLDFLUFROD]LRQHH[WUDFRUSRUHD

con impiego di HCU, dovranno essere immediatamente segnalati al Ministero della Salute secondo circolare.

Monitoraggio microbiologico ambientale

ΖOSLDQRGLPRQLWRUDJJLRªULYROWRDWXWWLLGLVSRVLWLYL+&8LQXVRGDOFKHSUHVHQWDQRVLVWHPLLGUDXOLFL

DULVFKLRGLFRQWDPLQD]LRQHGDPLFREDWWHULXQȇHYHQWXDOHSRVLWLYLW¢SUHYHGHOȇDWWLYD]LRQHLPPHGLDWDGHJOL

interventi per consentire l’interruzione in sicurezza dell’utilizzo del dispositivo HCU e l’espletamento GHOOHSURFHGXUHGLVDQLȴFD]LRQH

Informazione a pazienti e professionisti

/ȇLQIHWWLYRORJR JLRFD LO UXROR GL FDVH PDQDJHU GHO SHUFRUVR FOLQLFR DVVLVWHQ]LDOH GHȴQHQGR LO FRUUHWWR

LQTXDGUDPHQWR FOLQLFR H GLDJQRVWLFR DL ȴQL GL FRQIHUPD R HVFOXVLRQH GHO VRVSHWWR FRQ SDUWLFRODUH

ULIHULPHQWRDOOȇHVHFX]LRQHGLSUHOLHYLGLPDWHULDOHVLJQLȴFDWLYRSHUHVDPHFROWXUDOHDOOȇLQYLRGHOORVWHVVR

SUHVVRLODERUDWRULGLFRPSHWHQ]DHDOOȇHYHQWXDOHSUHVFUL]LRQHGLWUDWWDPHQWLVSHFLȴFLQHLFDVLFRQIHUPDWL

7XWWDYLDDQFKHLPHGLFLGLPHGLFLQDJHQHUDOHLSHGLDWULGLIDPLJOLDLPHGLFLVSHFLDOLVWLRSHUDQWLVXOWHUULWRULR

UHJLRQDOHLQSDUWLFRODUHFDUGLRORJLFDUGLRFKLUXUJKLDQHVWHVLVWLSQHXPRORJLPHGLFLGLPHGLFLQDLQWHUQD

HGȇXUJHQ]DGHYRQRHVVHUHLQIRUPDWLVXOWHPDHVXOOHLQGLFD]LRQLUHODWLYHDOSHUFRUVRFOLQLFRDOȴQHGL

garantire un iter condiviso.

ΖO SLDQR GL LQIRUPD]LRQH ª LQROWUH ULYROWR DL FLWWDGLQL UHVLGHQWL VXO WHUULWRULR UHJLRQDOH FRQ LO GXSOLFH

RELHWWLYRGLIRUQLUHFRUUHWWDLQIRUPD]LRQHHVHQVLELOL]]D]LRQHHYLWDUHGDQQRVLDOODUPLVPLHGLQWHUFHWWDUH

SUHFRFHPHQWHFRORURFKHSUHVHQWLQRVHJQLHVLQWRPLVRVSHWWLWUDLSD]LHQWLHVSRVWL

(8)

216

L

ASORVEGLIANZADELLE MALATTIEINFETTIVEIN

T

OSCANA

%LEOLRJUDȴD

• &LUFRODUH0LQLVWHURGHOODVDOXWHȂ5DFFRPDQGD]LRQLSHULOFRQWUROORGHOOȇLQIH]LRQHGD0\FREDFWHULXPFKLPDHUH

LQΖWDOLDKWWSZZZWURYDQRUPHVDOXWHJRYLWQRUPHUHQGHU1RUPVDQ3GI"DQQR FRG/HJ SDUWH

VHULH QXOO

• &LUFRODUH0LQLVWHURGHOOD6DOXWHΖQGLFD]LRQLRSHUDWLYHULJXDUGDQWLJOLDVSHWWLGLODERUDWRULRLQPHULWRDLFDVLGL

LQIH]LRQHGD0\FREDFWHULXPFKLPDHUDLQΖWDOLDHDJJLRUQDPHQWRGHOOHLQIRUPD]LRQLGLVSRQLELOLKWWSZZZWURYDQRUPH

VDOXWHJRYLWQRUPHUHQGHU1RUPVDQ3GI"DQQR FRG/HJ SDUWH VHULH QXOO

• (XURSHDQ&HQWUHIRU'LVHDVH3UHYHQWLRQDQG&RQWURO(&'&(8SURWRFROIRUFDVHGHȴQLWLRQODERUDWRU\GLDJQRVLVDQG

HQYLURQPHQWDOWHVWLQJRI0\FREDFWHULXPFKLPDHUDLQIHFWLRQVSRWHQWLDOO\DVVRFLDWHGZLWKKHDWHUFRROHUXQLWVFDVH

GHȴQLWLRQDQGHQYLURQPHQWDOWHVWLQJPHWKRGRORJ\>ΖQWHUQHW>XSGDWHG$XJXVWFLWHG2FWREHU@

KWWSHFGFHXURSDHXHQSXEOLFDWLRQV3XEOLFDWLRQV(8SURWRFROIRU0FKLPDHUDSGI

• %ROOHWWLQR8ɝFLDOH5HJLRQH7RVFDQD'(/Ζ%(5$=Ζ21(PDU]RQΖQGLUL]]LDOOH$]LHQGHVDQLWDULHSHU

ODVRUYHJOLDQ]DGHOULVFKLRGL LQIH]LRQLGD0\FREDFWHULXP&KLPDHUDKWWSZZZUHJLRQHWRVFDQDLWEDQFDGDWL%857

&RQWHQXWR[PO"LG

• *UXSSRGLODYRUR1706Ζ0Ζ77RVFDQDGDWLQRQSXEEOLFDWLHGLQSDUWHSUHVHQWDWLDOOD9ΖΖ5LXQLRQH$QQXDOH6Ζ0Ζ7VH]LRQH

7RVFDQD$UH]]RH